𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic Neurologic Disease in Junín Virus-Infected Rats

✍ Scribed by Dr. Mercedes C. Weissenbacher; Eduardo F. Lascano; María M. Avila; María I. Berría


Book ID
102908345
Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
686 KB
Volume
20
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


The purpose of this study was to determine whether Junín virus persistence in CNS of rats was capable of inducing late neurologic disease. Following intracerebral inoculation of newborn animals with XJ strain, three distinct stages could be discerned: an early phase of acute disease, up to 30 days pi, with 5% mortality; an intermediate one, extending to 280 days pi, without clinical signs but with evident viral persistence; and a final period of chronic illness, featuring clinical neurologic syndrome, severe perivascular inflammatory reaction, PAP-labeled viral antigen in a few cerebral and cerebellar neurons, and virus recovery only by coculture. Late neurologic disease seems associated to the lack of effective clearance of brain virus, leading to viral persistence and long lasting immunologic stimulation. The importance of animal models for pathogenic studies on CNS persistent viral infections leading to late neurologic disease is stressed.


📜 SIMILAR VOLUMES


Protection of junín virus-infected marmo
✍ María M. Avila; Sergio R. Sarnoilovich; Rubén P. Laguens; Maria S. Merani; Merce 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Argentine hemorrhagic fever (Junín virus) is a human viral disease for which immune therapy proves effective, though a late neurologic syndrome is occasionally associated with the treatment. We attempted to determine in the infected marmoset Callithrix jacchus whether immune therapy leads to protect

Treatment of Junin Virus-Infected Guinea
✍ Dr. Richard H. Kenyon; David E. Green; Dr. Gerald A. Eddy; Clarence J. Peters 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Guinea pigs infected with Argentine hemorrhagic fever virus (Junin) were treated with pooled, homologous convalescent sera. Use of 15,000 or 5,000 therapeutic units of immune sera prevented all signs of illness when administered within 24 hr of infection. We could also prevent illness and death in i